This inventor holds 1 USPTO granted patent. Top assignee: Matrix Laboratories Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Prasanth Kumar Barik: Innovator in Pharmaceutical Processes
Introduction
Prasanth Kumar Barik is a notable inventor based in Secunderabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of novel crystalline forms of a specific compound. His work is characterized by a focus on innovative processes that enhance the efficacy and stability of pharmaceutical products.
Latest Patents
Prasanth Kumar Barik holds a patent for the "Process for the preparation of O-desmethylvenlafaxine succinate polymorphic forms." This invention relates to the preparation of novel crystalline Desmethylvenlafaxine succinate polymorphic Forms-A and B. Additionally, it encompasses novel processes for the preparation of O-Desmethylvenlafaxine succinate polymorphic Forms-(I), (II), (III), and amorphous forms. This patent highlights his expertise in developing advanced pharmaceutical formulations.
Career Highlights
Barik is currently associated with Matrix Laboratories Limited, where he applies his innovative skills to enhance pharmaceutical processes. His work at Matrix Laboratories has positioned him as a key player in the development of new drug formulations. His dedication to research and development has contributed to the company's reputation for quality and innovation in the pharmaceutical industry.
Collaborations
Throughout his career, Prasanth Kumar Barik has collaborated with esteemed colleagues, including Jagan Mohana Chary Tummanapally and Ramakoteswara Rao Jetti. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical research.
Conclusion
Prasanth Kumar Barik is a distinguished inventor whose work in pharmaceutical processes has made a significant impact on the industry. His innovative approach and dedication to research continue to drive advancements in drug formulation and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile